CSOP China Healthcare Disruption Index ETF (HKG:3174)
4.280
+0.176 (4.29%)
At close: Sep 5, 2025
HKG:3174 Holdings Information
HKG:3174 is an equity ETF with a total of 24 individual holdings. The top holdings are Sino Biopharmaceutical stock at 9.42%, WuXi Biologics at 8.91%, Innovent Biologics at 8.69%, WuXi AppTec at 8.54%, and CSPC Pharmaceutical Group at 8.36%.
Total Holdings
24
Top 10 Percentage
75.84%
Asset Class
Equity
ETF Category
Total Market
Assets
1.18B
PE Ratio
31.43
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 1177 | Sino Biopharmaceutical Limited | 9.42% |
2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 8.91% |
3 | HKG: 1801 | Innovent Biologics, Inc. | 8.69% |
4 | HKG: 2359 | WuXi AppTec Co., Ltd. | 8.54% |
5 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 8.36% |
6 | HKG: 9926 | Akeso, Inc. | 7.66% |
7 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 7.33% |
8 | HKG: 1276 | Jiangsu Hengrui Medicine Co., Ltd. | 6.05% |
9 | HKG: 0241 | Alibaba Health Information Technology Limited | 5.76% |
10 | HKG: 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 5.12% |
11 | HKG: 1877 | Shanghai Junshi Biosciences Co., Ltd. | 3.34% |
12 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 3.27% |
13 | HKG: 1548 | Genscript Biotech Corporation | 2.91% |
14 | HKG: 1513 | Livzon Pharmaceutical Group Inc. | 2.81% |
15 | HKG: 2252 | Shanghai MicroPort MedBot (Group) Co., Ltd. | 2.48% |
16 | HKG: 9995 | RemeGen Co., Ltd. | 2.42% |
17 | HKG: 3320 | China Resources Pharmaceutical Group Limited | 1.93% |
18 | HKG: 0867 | China Medical System Holdings Limited | 1.19% |
19 | HKG: 2162 | Keymed Biosciences Inc. | 1.02% |
20 | CASBF | CanSino Biologics Inc. | 0.79% |
21 | HKG: 2607 | Shanghai Pharmaceuticals Holding Co., Ltd | 0.67% |
22 | n/a | Cash | 0.60% |
23 | HKG: 0512 | Grand Pharmaceutical Group Limited | 0.55% |
24 | HKG: 6639 | Arrail Group Limited | 0.18% |
As of Sep 5, 2025